Group One Trading’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,338
Closed -$12.2K 8202
2023
Q3
$12.2K Hold
3,338
﹤0.01% 6234
2023
Q2
$16.1K Hold
3,338
﹤0.01% 6125
2023
Q1
$15.7K Buy
3,338
+3
+0.1% +$15 ﹤0.01% 5671
2022
Q4
$16.5K Buy
+3,335
New +$20.2K ﹤0.01% 5720
2021
Q2
Sell
-54
Closed -$898 8587
2021
Q1
$1K Sell
54
-900
-94% -$21.6K ﹤0.01% 7480
2020
Q4
$18K Buy
954
+100
+12% +$1.66K ﹤0.01% 5576
2020
Q3
$9K Buy
+854
New +$9.88K ﹤0.01% 5469
2017
Q2
Sell
-20
Closed -$1K 5092
2017
Q1
$1K Hold
20
﹤0.01% 4519
2016
Q4
$1K Hold
20
﹤0.01% 4326
2016
Q3
$1K Hold
20
﹤0.01% 4455
2016
Q2
$1K Hold
20
﹤0.01% 4524
2016
Q1
$1K Buy
+20
New +$1.06K ﹤0.01% 4457
2015
Q3
Sell
-453
Closed -$41K 5200
2015
Q2
$41K Buy
+453
New +$39.2K ﹤0.01% 3662
2014
Q4
Sell
-1,590
Closed -$137K 5277
2014
Q3
$145K Buy
1,590
+389
+32% +$42.1K ﹤0.01% 2664
2014
Q2
$138K Buy
+1,201
New +$142K ﹤0.01% 2709
2014
Q1
Sell
-9,178
Closed -$1.2M 5585
2013
Q4
$1.15M Buy
9,178
+3,129
+52% +$376K 0.02% 1002
2013
Q3
$658K Buy
6,049
+2,519
+71% +$246K 0.01% 1371
2013
Q2
$297K Buy
+3,530
New +$293K 0.01% 1800

Other funds holding TRIB

Group One Trading's TRIB Position: Q4 2023 in Review

Group One Trading sold out of Trinity Biotech (TRIB) in Q4 2023, closing a stake of 3,338 shares — an estimated $12.2K sold.

Group One Trading first reported a position in TRIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2013. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.

  • Group One Trading reported no remaining Trinity Biotech position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 3,338 Trinity Biotech shares in Q4 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Trinity Biotech in Q2 2013 and held it in 18 quarters.
  • Group One Trading's Trinity Biotech position peaked at $1.15M in Q4 2013.
  • 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.